Oncothyreon, Inc. Company Information

Overview

Oncothyreon, Inc. mainly operate in the Home Health Care Services industry. Currently they have estimated 50 employees.


url icon Website:
http://www.oncothyreon.com
Social Social Social Social
size company icon Size:

50 employees

phone icon Phone Number:
+1 (425) 450-xxxx
+1 (206) 801-xxxx
Fax
+1 (206) 801-xxxx
+1 (425) 450-xxxx
Fax
industry icon Industry:

Home Health Care Services

Employees at Oncothyreon, Inc.

Showing 7 of 17
JOB TITLE WORK EMAIL WORK PHONE LOCATION
Executive Vice President and General Manager @apax.com
-
San Francisco, California VIEW PROFILE
Vice President, Protocell Operations @oncothyreon.com
-
California VIEW PROFILE
Lab Manager Eh and S Officer @oncothyreon.com
-
Seattle, Washington VIEW PROFILE
Director, Human Resources @oncothyreon.com
-
Seattle, Washington VIEW PROFILE
Controller @oncothyreon.com
-
Seattle, Washington VIEW PROFILE
Employee @oncothyreon.com
-
Seattle, Washington VIEW PROFILE
Director, Clinical Research @oncothyreon.com
-
Seattle, Washington VIEW PROFILE
Executive Vice President and General Manager
San Francisco, California
Vice President, Protocell Operations
California
Lab Manager Eh and S Officer
Seattle, Washington
Director, Human Resources
Seattle, Washington
Controller
Seattle, Washington
Employee
Seattle, Washington
Director, Clinical Research
Seattle, Washington

Oncothyreon, Inc.'s Email Format

We found 5 email formats used by Oncothyreon, Inc. employees. The most common Oncothyreon, Inc. email format is first_initial last ex.(jdoe@oncothyreon.com) being used 72% of the time.

Frequently Asked Questions About Oncothyreon, Inc.

What is Oncothyreon, Inc.'s website address?

Oncothyreon, Inc.'s website address is http://www.oncothyreon.com

What is Oncothyreon, Inc.'s phone number?

Oncothyreon, Inc.'s phone number is +1 (425) 450-xxxx

How many email formats does Oncothyreon, Inc. use?

Oncothyreon, Inc. uses 5 email formats

How many employees work at Oncothyreon, Inc.?

Approximately 50 employees work at Oncothyreon, Inc.